Skip to main content

Advertisement

Log in

Marked improvement of Churg–Strauss vasculitis with intravenous gamma globulins during pregnancy

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Churg–Strauss syndrome (CSS) is an extremely rare disease, and even less common in women of childbearing age. Patients with severe disease or those who are un-responsive to corticosteroids are usually treated with cytotoxic drugs, especially cyclophosphmide. Intravenous immunoglobulin (IVIg) has became a promising, but not completely accepted, form of treatment for systemic vasculitis that is un-responsive to standard therapy. We report a case of a woman who presented with a CSS flare during pregnancy. Because of mono-neuritis, treatment with IVIg was instituted with successful results. Our case not only supports the beneficial effect of IVIg in CSS, but it also illustrates its successful and safe use in a patient who was pregnant. We discuss the indication of IVIg during the course of anti-neutrophil cytoplasm antigen (ANCA) vasculitis during the pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–1100

    Article  CAS  PubMed  Google Scholar 

  2. Noth I, Strek ME, Leff AR (2003) Churg–Strauss syndrome. Lancet 361:587–594

    Article  PubMed  Google Scholar 

  3. Churg A (2001) Recent advances in the diagnosis of Churg–Strauss syndrome. Mod Pathol 14:1284–1293

    Article  CAS  PubMed  Google Scholar 

  4. Richter C, Schnabel A, Csernok E, De Groot K, Reinhold-Keller E et al (1995) Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin. Clin Exp Immunol 101:2–7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Mouthon L (1999) Treatment of ANCA-positive systemic vasculitis with intravenous immunoglobins. Rev Med Interne 20(Suppl 4):431s–435s

    Article  PubMed  Google Scholar 

  6. Danieli MG, Cappelli M, Malcangi G, Logullo F, Salvi A et al (2004) Long term effectiveness of intravenous immunoglobulin in Churg–Strauss syndrome. Ann Rheum Dis 63:1649–1654

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Hamilos DL, Christensen J (1991) Treatment of Churg–Strauss syndrome with high-dose intravenous immunoglobulin. J Allergy Clin Immunol 88:823–824

    Article  CAS  PubMed  Google Scholar 

  8. Armentia A, Fernandez A, Sanchez P, de la Fuente R, Sanchis E et al (1993) Asthma and vasculitis. Response to intravenous immunoglobulins. Allergol Immunopathol (Madr) 21:47–52

    CAS  Google Scholar 

  9. Levy Y, George J, Fabbrizzi F, Rotman P, Paz Y et al (1999) Marked improvement of Churg–Strauss vasculitis with intravenous gammaglobulins. South Med J 92:412–414

    Article  CAS  PubMed  Google Scholar 

  10. Rutberg SA, Ward DE, Roth BJ (2002) Churg–Strauss syndrome and pregnancy: successful treatment with intravenous immunoglobulin. J Clin Rheumatol 8:151–156

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arnaud Hot.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hot, A., Perard, L., Coppere, B. et al. Marked improvement of Churg–Strauss vasculitis with intravenous gamma globulins during pregnancy. Clin Rheumatol 26, 2149–2151 (2007). https://doi.org/10.1007/s10067-007-0628-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-007-0628-8

Keywords

Navigation